+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Advanced Therapy Medicinal Products - Global Strategic Business Report

  • PDF Icon

    Report

  • 92 Pages
  • April 2023
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5301748

Global Advanced Therapy Medicinal Products Market to Reach $35.5 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Advanced Therapy Medicinal Products estimated at US$8.3 Billion in the year 2022, is projected to reach a revised size of US$35.5 Billion by 2030, growing at a CAGR of 19.9% over the analysis period 2022-2030. Tissue Engineered Product, one of the segments analyzed in the report, is projected to record 20.6% CAGR and reach US$15.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Cell Therapy segment is readjusted to a revised 19.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.4 Billion, While China is Forecast to Grow at 19.1% CAGR

The Advanced Therapy Medicinal Products market in the U.S. is estimated at US$2.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$6.1 Billion by the year 2030 trailing a CAGR of 19.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.7% and 17% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 14.7% CAGR.

Select Competitors (Total 36 Featured) -

  • Bluebird Bio, Inc.
  • Celgene Corporation
  • Gilead Lifesciences, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Kolon TissueGene, Inc.
  • MEDIPOST
  • Novartis AG
  • Organogenesis, Inc.
  • PHARMICELL Co., Ltd
  • Spark Therapeutics, Inc.
  • UniQure N.V.
  • Vericel Corporation

What`s New for 2023?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Frequently Asked Questions about the Global Market for Advanced Therapy Medicinal Products

What is the estimated value of the Global Market for Advanced Therapy Medicinal Products?

The Global Market for Advanced Therapy Medicinal Products was estimated to be valued at $8.3 Billion in 2022.

What is the growth rate of the Global Market for Advanced Therapy Medicinal Products?

The growth rate of the Global Market for Advanced Therapy Medicinal Products is 19.9%, with an estimated value of $35.5 Billion by 2030.

What is the forecasted size of the Global Market for Advanced Therapy Medicinal Products?

The Global Market for Advanced Therapy Medicinal Products is estimated to be worth $35.5 Billion by 2030.

Who are the key companies in the Global Market for Advanced Therapy Medicinal Products?

Key companies in the Global Market for Advanced Therapy Medicinal Products include Bluebird Bio, Inc., Celgene Corporation, Gilead Lifesciences, Inc., JCR Pharmaceuticals Co., Ltd., Kolon TissueGene, Inc., MEDIPOST, Novartis AG, Organogenesis, Inc., PHARMICELL Co., Ltd and Spark Therapeutics, Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Advanced Therapy Medicinal Products - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Advanced Therapy Medicinal Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Advanced Therapy Medicinal Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Tissue Engineered Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Tissue Engineered Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Tissue Engineered Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Gene Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for CAR-T Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for CAR-T Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for CAR-T Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 16: World Advanced Therapy Medicinal Products Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 17: USA Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 18: USA Historic Review for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 19: USA 16-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Sales for Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2014, 2023 & 2030
CANADA
  • Table 20: Canada Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 21: Canada Historic Review for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 22: Canada 16-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Sales for Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2014, 2023 & 2030
JAPAN
  • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 23: Japan Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 24: Japan Historic Review for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 25: Japan 16-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Sales for Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2014, 2023 & 2030
CHINA
  • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 26: China Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 27: China Historic Review for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 28: China 16-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Sales for Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2014, 2023 & 2030
EUROPE
  • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 29: Europe Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 30: Europe Historic Review for Advanced Therapy Medicinal Products by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 31: Europe 16-Year Perspective for Advanced Therapy Medicinal Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 32: Europe Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 33: Europe Historic Review for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 34: Europe 16-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Sales for Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2014, 2023 & 2030
FRANCE
  • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 35: France Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 36: France Historic Review for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 37: France 16-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Sales for Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2014, 2023 & 2030
GERMANY
  • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 38: Germany Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: Germany Historic Review for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 40: Germany 16-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Sales for Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2014, 2023 & 2030
ITALY
  • Table 41: Italy Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 42: Italy Historic Review for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 43: Italy 16-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Sales for Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2014, 2023 & 2030
UNITED KINGDOM
  • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 44: UK Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: UK Historic Review for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 46: UK 16-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Sales for Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2014, 2023 & 2030
REST OF EUROPE
  • Table 47: Rest of Europe Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 48: Rest of Europe Historic Review for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 49: Rest of Europe 16-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Sales for Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2014, 2023 & 2030
ASIA-PACIFIC
  • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 50: Asia-Pacific Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 51: Asia-Pacific Historic Review for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 52: Asia-Pacific 16-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Sales for Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2014, 2023 & 2030
REST OF WORLD
  • Table 53: Rest of World Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 54: Rest of World Historic Review for Advanced Therapy Medicinal Products by Type - Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 55: Rest of World 16-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Sales for Tissue Engineered Product, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2014, 2023 & 2030
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Bluebird Bio, Inc.
  • Celgene Corporation
  • Gilead Lifesciences, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Kolon TissueGene, Inc.
  • MEDIPOST
  • Novartis AG
  • Organogenesis, Inc.
  • PHARMICELL Co., Ltd
  • Spark Therapeutics, Inc.
  • UniQure N.V.
  • Vericel Corporation